Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers - Implications for the epilepsy seen in the dementia FENIB

被引:42
作者
Belorgey, D
Sharp, LK
Crowther, DC
Onda, M
Johansson, J
Lomas, DA
机构
[1] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2XY, England
[2] Osaka Womens Univ, Fac Sci, Dept Environm Sci, Sakai, Osaka, Japan
[3] Swedish Univ Agr Sci, Dept Mol Biosci, Uppsala, Sweden
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 16期
关键词
conformational diseases; neuroserpin; polymerization; serpin; serpinopathies;
D O I
10.1111/j.1432-1033.2004.04270.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.
引用
收藏
页码:3360 / 3367
页数:8
相关论文
共 29 条
[1]  
AULAK KS, 1993, J BIOL CHEM, V268, P18088
[2]   Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro [J].
Barker-Carlson, K ;
Lawrence, DA ;
Schwartz, BS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :46852-46857
[3]   Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and α1-proteinase inhibitor [J].
Belorgey, D ;
Bieth, JG .
BIOCHEMISTRY, 1998, 37 (46) :16416-16422
[4]   Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro [J].
Belorgey, D ;
Crowther, DC ;
Mahadeva, R ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17367-17373
[5]  
BIETH JG, 1995, METHOD ENZYMOL, V248, P59
[6]   Crystal structure of neuroserpin:: a neuronal serpin involved in a conformational disease [J].
Briand, C ;
Kozlov, SV ;
Sonderegger, P ;
Grütter, MG .
FEBS LETTERS, 2001, 505 (01) :18-22
[7]   THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP) [J].
BRUCE, D ;
PERRY, DJ ;
BORG, JY ;
CARRELL, RW ;
WARDELL, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2265-2274
[8]   Mechanisms of disease -: Alpha1-antitrypsin deficiency -: A model for conformational diseases [J].
Carrell, RW ;
Lomas, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) :45-53
[9]   Nucleation of α1-antichymotrypsin polymerization [J].
Crowther, DC ;
Serpell, LC ;
Dafforn, TR ;
Gooptu, B ;
Lomas, DA .
BIOCHEMISTRY, 2003, 42 (08) :2355-2363
[10]   A kinetic mechanism for the polymerization of α1-antitrypsin [J].
Dafforn, TR ;
Mahadeva, R ;
Elliott, PR ;
Sivasothy, P ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9548-9555